Zepp Health Corporation
ZEPP
$2.53
-$0.13-4.89%
NYSE
| 12/31/2024 | 09/30/2024 | 03/31/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 298.58M | 298.63M | 352.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 298.58M | 298.63M | 352.87M |
| Cost of Revenue | -- | -- | 206.53M | 206.56M | 260.51M |
| Gross Profit | -- | -- | 92.05M | 92.06M | 92.36M |
| SG&A Expenses | -- | -- | 68.62M | 68.57M | 71.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | 322.80M | 322.74M | 383.30M |
| Operating Income | -- | -- | -24.22M | -24.11M | -30.44M |
| Income Before Tax | -- | -- | -24.54M | -24.43M | -33.51M |
| Income Tax Expenses | -- | -- | 1.26M | 1.26M | -2.43M |
| Earnings from Continuing Operations | -- | -- | -25.79 | -25.68 | -31.08 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 70.20K | 70.40K | 66.40K |
| Net Income | -- | -- | -25.72M | -25.61M | -31.01M |
| EBIT | -- | -- | -24.22M | -24.11M | -30.44M |
| EBITDA | -- | -- | -16.38M | -16.30M | -22.35M |
| EPS Basic | -- | -- | -26.10 | -25.98 | -32.47 |
| Normalized Basic EPS | -- | -- | -0.53 | -0.52 | -0.86 |
| EPS Diluted | -- | -- | -27.43 | -26.16 | -33.76 |
| Normalized Diluted EPS | -- | -- | -0.53 | -0.52 | -0.86 |
| Average Basic Shares Outstanding | -- | -- | 61.73M | 61.73M | 60.83M |
| Average Diluted Shares Outstanding | -- | -- | 3.91M | 3.91M | 3.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |